Table 2.
MRI |
DM |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Case | Age | Sex | Type | Location of infarction | Alb | TC | UP | Day | E | Duration | NS type |
1 | 50 | F | LAA | R. MCA (BAD) | 3 | 284 | 4 | 8.4 | ++ | 15 | DN s/p |
2 | 53 | F | LAA | R. MCA | 1.8 | 707 | 4 | 8.6 | ++ | – | Amyloidosis |
3 | 59 | M | LAA | R. ant. choroidal A | 2.1 | 336 | 3 | 9.5 | ++ | 5 | DN s/p |
4 | 62 | M | LAA | L. MCA | 2.8 | 407 | 4 | 6.4 | ++ | 30 | DN s/p |
5 | 79 | M | LAA | R. MCA (R. IC occlusion) | 2.8 | 315 | 4 | ++ | 20 | DN s/p | |
6 | 70 | M | LAA | R. MCA, | 1.9 | 326 | 3 | + | 10 | DN s/p | |
7 | 65 | M | SVO | L. basal ganglia | 2.7 | 264 | 4 | 6.5 | ++ | – | MPGN |
8 | 68 | M | SVO | R. basal ganglia | 3 | 285 | 3 | ++ | 2 | DN s/p | |
9 | 69 | M | SVO | R. basal ganglia | 3 | 299 | 3 | ++ | 4 | DN s/p | |
10 | 69 | M | CE | R. MCA | 3 | 264 | 4 | ++ | 8 | DN s/p |